The invention provides a transgenic Glycine max event MON87751， plants， plant cells， seeds， plant parts， progeny plants， and commodity products comprising event MON87751. The invention also provides p
Introduction: A variety of gene rearrangements and molecular alterations are key drivers in the pathobiology of acute leukemia and myeloid disorders; current classification systems increasingly incorp
